Dose–response to 3 months of quercetin-containing supplements on metabolite and quercetin conjugate profile in adults
Quercetin, a flavonol in fruits and vegetables, has been demonstrated to have antioxidant, anti-inflammatory and immunomodulating influences. The purpose of the present study was to determine if quercetin, vitamin C and niacin supplements (Q-500 = 500 mg/d of quercetin, 125 mg/d of vitamin C and 5 m...
Saved in:
| Published in | British journal of nutrition Vol. 109; no. 11; pp. 1923 - 1933 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Cambridge, UK
Cambridge University Press
14.06.2013
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Quercetin, a flavonol in fruits and vegetables, has been demonstrated to have antioxidant, anti-inflammatory and immunomodulating influences. The purpose of the present study was to determine if quercetin, vitamin C and niacin supplements (Q-500 = 500 mg/d of quercetin, 125 mg/d of vitamin C and 5 mg/d of niacin; Q-1000 = 1000 mg/d of quercetin, 250 mg/d of vitamin C and 10 mg/d of niacin) would alter small-molecule metabolite profiles and serum quercetin conjugate levels in adults. Healthy adults (fifty-eight women and forty-two men; aged 40–83 years) were assigned using a randomised double-blinded placebo-controlled trial to one of three supplement groups (Q-1000, Q-500 or placebo). Overnight fasted blood samples were collected at 0, 1 and 3 months. Quercetin conjugate concentrations were measured using ultra-performance liquid chromatography (UPLC)-MS/MS, and metabolite profiles were measured using two MS platforms (UPLC-quadrupole time-of-flight MS (TOFMS) and GC-TOFMS). Statistical procedures included partial least square discriminant analysis (PLS-DA) and linear mixed model analysis with repeated measures. After accounting for age, sex and BMI, quercetin supplementation was associated with significant shifts in 163 metabolites/quercetin conjugates (false discovery rate, P< 0·05). The top five metabolite shifts were an increase in serum guaiacol, 2-oxo-4-methylthiobutanoic acid, allocystathionine and two bile acids. Inflammatory and oxidative stress metabolites were not affected. PLS-DA revealed a clear separation only between the 1000 mg/d and placebo groups (Q2Y= 0·763). The quercetin conjugate, isorhamnetin-3-glucuronide, had the highest concentration at 3 months followed by quercetin-3-glucuronide, quercetin-3-sulphate and quercetin diglucuronide. In human subjects, long-term quercetin supplementation exerts disparate and wide-ranging metabolic effects and changes in quercetin conjugate concentrations. Metabolic shifts were apparent at the 1000 mg/d dose; further research is required to understand the health implications of these shifts. |
|---|---|
| AbstractList | Quercetin, a flavonol in fruits and vegetables, has been demonstrated to have antioxidant, anti-inflammatory and immunomodulating influences. The purpose of the present study was to determine if quercetin, vitamin C and niacin supplements (Q-500 = 500 mg/d of quercetin, 125 mg/d of vitamin C and 5 mg/d of niacin; Q-1000 = 1000 mg/d of quercetin, 250 mg/d of vitamin C and 10 mg/d of niacin) would alter small-molecule metabolite profiles and serum quercetin conjugate levels in adults. Healthy adults (fifty-eight women and forty-two men; aged 40–83 years) were assigned using a randomised double-blinded placebo-controlled trial to one of three supplement groups (Q-1000, Q-500 or placebo). Overnight fasted blood samples were collected at 0, 1 and 3 months. Quercetin conjugate concentrations were measured using ultra-performance liquid chromatography (UPLC)-MS/MS, and metabolite profiles were measured using two MS platforms (UPLC-quadrupole time-of-flight MS (TOFMS) and GC-TOFMS). Statistical procedures included partial least square discriminant analysis (PLS-DA) and linear mixed model analysis with repeated measures. After accounting for age, sex and BMI, quercetin supplementation was associated with significant shifts in 163 metabolites/quercetin conjugates (false discovery rate, P< 0·05). The top five metabolite shifts were an increase in serum guaiacol, 2-oxo-4-methylthiobutanoic acid, allocystathionine and two bile acids. Inflammatory and oxidative stress metabolites were not affected. PLS-DA revealed a clear separation only between the 1000 mg/d and placebo groups (Q²Y= 0·763). The quercetin conjugate, isorhamnetin-3-glucuronide, had the highest concentration at 3 months followed by quercetin-3-glucuronide, quercetin-3-sulphate and quercetin diglucuronide. In human subjects, long-term quercetin supplementation exerts disparate and wide-ranging metabolic effects and changes in quercetin conjugate concentrations. Metabolic shifts were apparent at the 1000 mg/d dose; further research is required to understand the health implications of these shifts. Quercetin, a flavonol in fruits and vegetables, has been demonstrated to have antioxidant, anti-inflammatory and immunomodulating influences. The purpose of the present study was to determine if quercetin, vitamin C and niacin supplements (Q-500 = 500 mg/d of quercetin, 125 mg/d of vitamin C and 5 mg/d of niacin; Q-1000 = 1000 mg/d of quercetin, 250 mg/d of vitamin C and 10 mg/d of niacin) would alter small-molecule metabolite profiles and serum quercetin conjugate levels in adults. Healthy adults (fifty-eight women and forty-two men; aged 40-83 years) were assigned using a randomised double-blinded placebo-controlled trial to one of three supplement groups (Q-1000, Q-500 or placebo). Overnight fasted blood samples were collected at 0, 1 and 3 months. Quercetin conjugate concentrations were measured using ultra-performance liquid chromatography (UPLC)-MS/MS, and metabolite profiles were measured using two MS platforms (UPLC-quadrupole time-of-flight MS (TOFMS) and GC-TOFMS). Statistical procedures included partial least square discriminant analysis (PLS-DA) and linear mixed model analysis with repeated measures. After accounting for age, sex and BMI, quercetin supplementation was associated with significant shifts in 163 metabolites/quercetin conjugates (false discovery rate, P<0·05). The top five metabolite shifts were an increase in serum guaiacol, 2-oxo-4-methylthiobutanoic acid, allocystathionine and two bile acids. Inflammatory and oxidative stress metabolites were not affected. PLS-DA revealed a clear separation only between the 1000 mg/d and placebo groups (Q(2)Y = 0·763). The quercetin conjugate, isorhamnetin-3-glucuronide, had the highest concentration at 3 months followed by quercetin-3-glucuronide, quercetin-3-sulphate and quercetin diglucuronide. In human subjects, long-term quercetin supplementation exerts disparate and wide-ranging metabolic effects and changes in quercetin conjugate concentrations. Metabolic shifts were apparent at the 1000 mg/d dose; further research is required to understand the health implications of these shifts. Quercetin, a flavonol in fruits and vegetables, has been demonstrated to have antioxidant, anti-inflammatory and immunomodulating influences. The purpose of the present study was to determine if quercetin, vitamin C and niacin supplements (Q-500 = 500 mg/d of quercetin, 125 mg/d of vitamin C and 5 mg/d of niacin; Q-1000 = 1000 mg/d of quercetin, 250 mg/d of vitamin C and 10 mg/d of niacin) would alter small-molecule metabolite profiles and serum quercetin conjugate levels in adults. Healthy adults (fifty-eight women and forty-two men; aged 40–83 years) were assigned using a randomised double-blinded placebo-controlled trial to one of three supplement groups (Q-1000, Q-500 or placebo). Overnight fasted blood samples were collected at 0, 1 and 3 months. Quercetin conjugate concentrations were measured using ultra-performance liquid chromatography (UPLC)-MS/MS, and metabolite profiles were measured using two MS platforms (UPLC-quadrupole time-of-flight MS (TOFMS) and GC-TOFMS). Statistical procedures included partial least square discriminant analysis (PLS-DA) and linear mixed model analysis with repeated measures. After accounting for age, sex and BMI, quercetin supplementation was associated with significant shifts in 163 metabolites/quercetin conjugates (false discovery rate, P < 0·05). The top five metabolite shifts were an increase in serum guaiacol, 2-oxo-4-methylthiobutanoic acid, allocystathionine and two bile acids. Inflammatory and oxidative stress metabolites were not affected. PLS-DA revealed a clear separation only between the 1000 mg/d and placebo groups ( Q 2 Y = 0·763). The quercetin conjugate, isorhamnetin-3-glucuronide, had the highest concentration at 3 months followed by quercetin-3-glucuronide, quercetin-3-sulphate and quercetin diglucuronide. In human subjects, long-term quercetin supplementation exerts disparate and wide-ranging metabolic effects and changes in quercetin conjugate concentrations. Metabolic shifts were apparent at the 1000 mg/d dose; further research is required to understand the health implications of these shifts. Quercetin, a flavonol in fruits and vegetables, has been demonstrated to have antioxidant, anti-inflammatory and immunomodulating influences. The purpose of the present study was to determine if quercetin, vitamin C and niacin supplements (Q-500 = 500 mg/d of quercetin, 125 mg/d of vitamin C and 5 mg/d of niacin; Q-1000 = 1000 mg/d of quercetin, 250 mg/d of vitamin C and 10 mg/d of niacin) would alter small-molecule metabolite profiles and serum quercetin conjugate levels in adults. Healthy adults (fifty-eight women and forty-two men; aged 40-83 years) were assigned using a randomized double-blinded placebo-controlled trial to one of three supplement groups (Q-1000, Q-500 or placebo). Overnight fasted blood samples were collected at 0, 1 and 3 months. Quercetin conjugate concentrations were measured using ultra-performance liquid chromatography (UPLC)-MS/MS, and metabolite profiles were measured using two MS platforms (UPLC-quadrupole time-of-flight MS (TOFMS) and GC-TOFMS). Statistical procedures included partial least square discriminant analysis (PLS-DA) and linear mixed model analysis with repeated measures. After accounting for age, sex and BMI, quercetin supplementation was associated with significant shifts in 163 metabolites/quercetin conjugates (false discovery rate, P< 0·05). The top five metabolite shifts were an increase in serum guaiacol, 2-oxo-4-methylthiobutanoic acid, allocystathionine and two bile acids. Inflammatory and oxidative stress metabolites were not affected. PLS-DA revealed a clear separation only between the 1000 mg/d and placebo groups (Q 2 Y= 0·763). The quercetin conjugate, isorhamnetin-3-glucuronide, had the highest concentration at 3 months followed by quercetin-3-glucuronide, quercetin-3-sulphate and quercetin diglucuronide. In human subjects, long-term quercetin supplementation exerts disparate and wide-ranging metabolic effects and changes in quercetin conjugate concentrations. Metabolic shifts were apparent at the 1000 mg/d dose; further research is required to understand the health implications of these shifts. [PUBLICATION ABSTRACT] Quercetin, a flavonol in fruits and vegetables, has been demonstrated to have antioxidant, anti-inflammatory and immunomodulating influences. The purpose of the present study was to determine if quercetin, vitamin C and niacin supplements (Q-500 = 500 mg/d of quercetin, 125 mg/d of vitamin C and 5 mg/d of niacin; Q-1000 = 1000 mg/d of quercetin, 250 mg/d of vitamin C and 10 mg/d of niacin) would alter small-molecule metabolite profiles and serum quercetin conjugate levels in adults. Healthy adults (fifty-eight women and forty-two men; aged 40-83 years) were assigned using a randomised double-blinded placebo-controlled trial to one of three supplement groups (Q-1000, Q-500 or placebo). Overnight fasted blood samples were collected at 0, 1 and 3 months. Quercetin conjugate concentrations were measured using ultra-performance liquid chromatography (UPLC)-MS/MS, and metabolite profiles were measured using two MS platforms (UPLC-quadrupole time-of-flight MS (TOFMS) and GC-TOFMS). Statistical procedures included partial least square discriminant analysis (PLS-DA) and linear mixed model analysis with repeated measures. After accounting for age, sex and BMI, quercetin supplementation was associated with significant shifts in 163 metabolites/quercetin conjugates (false discovery rate, P<0·05). The top five metabolite shifts were an increase in serum guaiacol, 2-oxo-4-methylthiobutanoic acid, allocystathionine and two bile acids. Inflammatory and oxidative stress metabolites were not affected. PLS-DA revealed a clear separation only between the 1000 mg/d and placebo groups (Q(2)Y = 0·763). The quercetin conjugate, isorhamnetin-3-glucuronide, had the highest concentration at 3 months followed by quercetin-3-glucuronide, quercetin-3-sulphate and quercetin diglucuronide. In human subjects, long-term quercetin supplementation exerts disparate and wide-ranging metabolic effects and changes in quercetin conjugate concentrations. Metabolic shifts were apparent at the 1000 mg/d dose; further research is required to understand the health implications of these shifts.Quercetin, a flavonol in fruits and vegetables, has been demonstrated to have antioxidant, anti-inflammatory and immunomodulating influences. The purpose of the present study was to determine if quercetin, vitamin C and niacin supplements (Q-500 = 500 mg/d of quercetin, 125 mg/d of vitamin C and 5 mg/d of niacin; Q-1000 = 1000 mg/d of quercetin, 250 mg/d of vitamin C and 10 mg/d of niacin) would alter small-molecule metabolite profiles and serum quercetin conjugate levels in adults. Healthy adults (fifty-eight women and forty-two men; aged 40-83 years) were assigned using a randomised double-blinded placebo-controlled trial to one of three supplement groups (Q-1000, Q-500 or placebo). Overnight fasted blood samples were collected at 0, 1 and 3 months. Quercetin conjugate concentrations were measured using ultra-performance liquid chromatography (UPLC)-MS/MS, and metabolite profiles were measured using two MS platforms (UPLC-quadrupole time-of-flight MS (TOFMS) and GC-TOFMS). Statistical procedures included partial least square discriminant analysis (PLS-DA) and linear mixed model analysis with repeated measures. After accounting for age, sex and BMI, quercetin supplementation was associated with significant shifts in 163 metabolites/quercetin conjugates (false discovery rate, P<0·05). The top five metabolite shifts were an increase in serum guaiacol, 2-oxo-4-methylthiobutanoic acid, allocystathionine and two bile acids. Inflammatory and oxidative stress metabolites were not affected. PLS-DA revealed a clear separation only between the 1000 mg/d and placebo groups (Q(2)Y = 0·763). The quercetin conjugate, isorhamnetin-3-glucuronide, had the highest concentration at 3 months followed by quercetin-3-glucuronide, quercetin-3-sulphate and quercetin diglucuronide. In human subjects, long-term quercetin supplementation exerts disparate and wide-ranging metabolic effects and changes in quercetin conjugate concentrations. Metabolic shifts were apparent at the 1000 mg/d dose; further research is required to understand the health implications of these shifts. Quercetin, a flavonol in fruits and vegetables, has been demonstrated to have antioxidant, anti-inflammatory and immunomodulating influences. The purpose of the present study was to determine if quercetin, vitamin C and niacin supplements (Q-500 = 500 mg/d of quercetin, 125 mg/d of vitamin C and 5 mg/d of niacin; Q-1000 = 1000 mg/d of quercetin, 250 mg/d of vitamin C and 10 mg/d of niacin) would alter small-molecule metabolite profiles and serum quercetin conjugate levels in adults. Healthy adults (fifty-eight women and forty-two men; aged 40–83 years) were assigned using a randomised double-blinded placebo-controlled trial to one of three supplement groups (Q-1000, Q-500 or placebo). Overnight fasted blood samples were collected at 0, 1 and 3 months. Quercetin conjugate concentrations were measured using ultra-performance liquid chromatography (UPLC)-MS/MS, and metabolite profiles were measured using two MS platforms (UPLC-quadrupole time-of-flight MS (TOFMS) and GC-TOFMS). Statistical procedures included partial least square discriminant analysis (PLS-DA) and linear mixed model analysis with repeated measures. After accounting for age, sex and BMI, quercetin supplementation was associated with significant shifts in 163 metabolites/quercetin conjugates (false discovery rate, P< 0·05). The top five metabolite shifts were an increase in serum guaiacol, 2-oxo-4-methylthiobutanoic acid, allocystathionine and two bile acids. Inflammatory and oxidative stress metabolites were not affected. PLS-DA revealed a clear separation only between the 1000 mg/d and placebo groups (Q2Y= 0·763). The quercetin conjugate, isorhamnetin-3-glucuronide, had the highest concentration at 3 months followed by quercetin-3-glucuronide, quercetin-3-sulphate and quercetin diglucuronide. In human subjects, long-term quercetin supplementation exerts disparate and wide-ranging metabolic effects and changes in quercetin conjugate concentrations. Metabolic shifts were apparent at the 1000 mg/d dose; further research is required to understand the health implications of these shifts. |
| Author | Sha, Wei Meaney, Mary Pat Knab, Amy M. Nieman, David C. Shanely, R. Andrew Cialdella-Kam, Lynn |
| Author_xml | – sequence: 1 givenname: Lynn surname: Cialdella-Kam fullname: Cialdella-Kam, Lynn organization: 1Human Performance Laboratory, North Carolina Research Campus, Appalachian State University, 600 Laureate Way, Kannapolis, NC, USA – sequence: 2 givenname: David C. surname: Nieman fullname: Nieman, David C. email: niemandc@appstate.edu organization: 1Human Performance Laboratory, North Carolina Research Campus, Appalachian State University, 600 Laureate Way, Kannapolis, NC, USA – sequence: 3 givenname: Wei surname: Sha fullname: Sha, Wei organization: 2UNC Charlotte, Bioinformatics Services Division, Kannapolis, NC, USA – sequence: 4 givenname: Mary Pat surname: Meaney fullname: Meaney, Mary Pat organization: 1Human Performance Laboratory, North Carolina Research Campus, Appalachian State University, 600 Laureate Way, Kannapolis, NC, USA – sequence: 5 givenname: Amy M. surname: Knab fullname: Knab, Amy M. organization: 1Human Performance Laboratory, North Carolina Research Campus, Appalachian State University, 600 Laureate Way, Kannapolis, NC, USA – sequence: 6 givenname: R. Andrew surname: Shanely fullname: Shanely, R. Andrew organization: 1Human Performance Laboratory, North Carolina Research Campus, Appalachian State University, 600 Laureate Way, Kannapolis, NC, USA |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27382403$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23151341$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkt1qFTEQx4O02NPqA3gjC1LwZuvk62T3UuonFHqhXi_ZzeSYw26yJlnQO9-hL-Cz-Cg-iTn0lJaKCoGQ__z-w0xmjsmBDx4JeULhjAJVLz4AgKJUSMoAeKvYA7KiQsmardfsgKx24XoXPyLHKW3Ls6HQPiRHjFNJuaAr8vVVSPjr-1XENAefsMqh4j9_TMHnz6kKtvqyYBwwO18PRdPOO7-p0jLPI07oc2F8NWHWfRhdxkp7c2upimW7bHTR5xisG7EqojbLmNMjcmj1mPDx_j4hn968_nj-rr64fPv-_OVFPUghcy2MAZAMjOqt1RzXxg6CUoatFKYBavtWSQEWWCsVUAkcemmQQY_KqsbwE_L8Om-poBSWcje5NOA4ao9hSR1tmBRMlfN_lEsOgknGCvrsHroNS_SlkY6K3VCadUsL9XRPLf2Eppujm3T81t18fwFO94BOgx5t1H5w6ZZTvGECeOHUNTfEkFJE2w0u6-zKRKJ2Y0eh2y1E98dCFCe957xJ_i8P33v01EdnNninu7-6fgPysMa3 |
| CODEN | BJNUAV |
| CitedBy_id | crossref_primary_10_1016_j_jnutbio_2013_09_005 crossref_primary_10_1007_s00394_015_0862_9 crossref_primary_10_3892_or_2015_3886 crossref_primary_10_1016_j_bioorg_2019_03_047 crossref_primary_10_3389_fendo_2023_1273878 crossref_primary_10_1039_C9AY02528F crossref_primary_10_1016_j_biopha_2021_112039 crossref_primary_10_1016_j_heliyon_2023_e23565 crossref_primary_10_3164_jcbn_17_139 crossref_primary_10_1002_prp2_70021 crossref_primary_10_1080_10408398_2023_2299329 crossref_primary_10_2147_JIR_S228361 crossref_primary_10_1016_j_foodchem_2024_140262 crossref_primary_10_1016_j_bcp_2017_03_021 crossref_primary_10_1074_jbc_M114_621599 crossref_primary_10_1371_journal_pone_0128277 crossref_primary_10_1016_j_jpba_2025_116738 crossref_primary_10_3390_ijms20112681 crossref_primary_10_1007_s13668_015_0148_0 crossref_primary_10_1021_acs_analchem_4c06682 crossref_primary_10_1021_acs_jafc_9b02155 crossref_primary_10_1016_j_cbi_2024_111064 crossref_primary_10_1016_j_jnutbio_2016_03_011 crossref_primary_10_1039_D1FO00525A crossref_primary_10_1093_jpp_rgac093 crossref_primary_10_1021_acs_jproteome_7b00196 crossref_primary_10_3390_molecules19079606 crossref_primary_10_1007_s00210_014_0995_z crossref_primary_10_1186_s13046_022_02287_4 crossref_primary_10_3892_or_2015_4481 crossref_primary_10_1016_j_jinorgbio_2019_03_004 crossref_primary_10_1021_jf501548g crossref_primary_10_1007_s10162_016_0604_6 crossref_primary_10_3390_nu8050277 crossref_primary_10_1007_s13668_015_0137_3 crossref_primary_10_1016_j_biopha_2019_109604 crossref_primary_10_1089_act_2015_29038_eya crossref_primary_10_1016_j_jff_2017_10_047 |
| Cites_doi | 10.2174/138920111795909113 10.1016/j.clnu.2011.01.010 10.1016/j.jada.2011.01.013 10.1093/jac/dkg291 10.1093/ajcn/85.3.895 10.1016/j.leukres.2008.09.032 10.1128/CVI.13.3.319-328.2006 10.1021/jf8003042 10.2174/092986709789104966 10.1017/S0007114509359127 10.1038/bjp.2008.46 10.3109/10715760903407293 10.1016/S0378-5173(03)00363-6 10.1093/nar/gkn810 10.2220/biomedres.26.139 10.1093/jn/138.8.1417 10.1093/jn/135.7.1718 10.1093/ajcn/76.3.560 10.1099/0022-1317-69-7-1749 10.1016/j.bmc.2006.09.014 10.3390/nu4010029 10.3945/jn.109.117655 10.1207/s15327914nc5001_1 10.1021/pr9004162 10.1016/j.ijantimicag.2005.09.002 10.1152/ajpregu.90925.2008 10.1111/j.1467-842X.2000.tb00520.x 10.3945/ajcn.2009.28822 10.1093/jn/138.9.1615 10.1021/pr901081y 10.1016/j.bcp.2006.07.016 10.1002/eji.200425778 10.1016/j.atherosclerosis.2008.08.007 10.1017/S000711451000156X 10.1007/s10545-009-9006-9 10.1093/mutage/gep016 10.1093/jn/135.10.2299 10.1016/j.fct.2010.03.019 10.1017/S0007114511003242 10.1093/jn/137.3.718S 10.1093/nar/gkp896 10.1079/BJN20061809 10.1093/ajcn/88.4.1018 10.33549/physiolres.931088 10.1093/jn/137.11.2405 10.1016/S0167-4889(02)00328-2 10.1152/ajpregu.90319.2008 |
| ContentType | Journal Article |
| Copyright | Copyright © The Authors 2012 2014 INIST-CNRS |
| Copyright_xml | – notice: Copyright © The Authors 2012 – notice: 2014 INIST-CNRS |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QP 7RV 7T5 7X2 7X7 7XB 88E 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AN0 ATCPS AZQEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. KB0 M0K M0S M1P M2O MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U 7X8 7S9 L.6 |
| DOI | 10.1017/S0007114512003972 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Immunology Abstracts Agricultural Science Collection ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland British Nursing Database (Proquest) Agricultural & Environmental Science Collection ProQuest Central Essentials ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Agricultural Science Database Health & Medical Collection (Alumni Edition) Medical Database Research Library Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Central Basic ProQuest One Academic Eastern Edition Agricultural Science Collection British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA MEDLINE CrossRef Agricultural Science Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Diet & Clinical Nutrition |
| DocumentTitleAlternate | L. Cialdella-Kam et al. Quercetin supplement and metabolite profile |
| EISSN | 1475-2662 |
| EndPage | 1933 |
| ExternalDocumentID | 3022383851 23151341 27382403 10_1017_S0007114512003972 |
| Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -1D -2P -E. -~6 -~X .FH 09C 09E 0E1 0R~ 23N 2WC 3V. 4.4 5GY 5RE 5VS 6J9 6PF 74X 74Y 7RV 7X2 7X7 7~V 88E 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 9M5 AAAZR AABES AABWE AACJH AAFWJ AAGFV AAHBH AAIKC AAKTX AAMNQ AAMNW AARAB AASVR AATID AATMM AAUIS AAUKB AAWTL AAZAQ ABBJB ABBXD ABFBI ABGDZ ABJNI ABKKG ABKMT ABMWE ABQTM ABROB ABUWG ABVKB ABVZP ABWCF ABXAU ABZCX ACBEK ACBMC ACDLN ACGFS ACIMK ACPRK ACUIJ ACYZP ACZBM ACZUX ACZWT ADAZD ADBBV ADDNB ADFEC ADFRT ADKIL ADVJH AEBAK AEHGV AEMTW AENEX AENGE AEPLO AEUYN AEYHU AEYYC AFFUJ AFKQG AFKRA AFLOS AFLVW AFOSN AFRAH AFRIC AFUTZ AFZFC AGABE AGJUD AGLWM AHIPN AHLTW AHMBA AHQXX AHRGI AIGNW AIHIV AIOIP AISIE AJ7 AJCYY AJPFC AJQAS ALMA_UNASSIGNED_HOLDINGS ALWZO AN0 ANPSP AQJOH ARABE ATCPS ATUCA AUXHV AYIQA AZGZS AZQEC BAWUL BBLKV BENPR BHPHI BKEYQ BLZWO BMAJL BNQBC BPHCQ BQFHP BRIRG BVXVI C0O CBIIA CCPQU CCQAD CFAFE CHEAL CJCSC CS3 DIK DOHLZ DU5 DWQXO E3Z EBS EJD EX3 F5P FYUFA GNUQQ GUQSH HCIFZ HG- HH5 HMCUK HST HZ~ I.6 I.7 IH6 IOEEP IOO IS6 I~P J36 J38 J3A JHPGK JKPOH JQKCU JVRFK KCGVB KFECR L7B L98 LHUNA LW7 M-V M0K M1P M2O M7~ NAPCQ NIKVX O9- OK1 OVD P6G PCD PQQKQ PROAC PSQYO Q2X RAMDC RCA RIG ROL RR0 S6- S6U SAAAG SJN SY4 T9M TEORI TR2 UCJ UKHRP UT1 UU6 WFFJZ WH7 WOW WQ3 WXU WYP Y6R ZMEZD ZYDXJ ~KM AAYXX ABXHF AKMAY CITATION PHGZM PHGZT -1F -2V -~N .55 .GJ 354 3EH 3O- 53G 6~7 AANRG AAYJJ ABBZL ABHFL ABVFV ABZUI ACEJA ACETC ACOZI ACRPL ADNMO ADOVH ADOVT AEBPU AEMFK AENCP AFFNX AGKLZ AI. AKZCZ ALEEW ANOYL ARZZG BCGOX BESQT BGHMG BJBOZ C1A CAG CCUQV CDIZJ CFBFF CGQII COF EGQIC I.9 IQODW KAFGG M8. NMFBF NZEOI OHT UAP VH1 X7M ZCG ZDLDU ZGI ZJOSE ZXP ~V1 CGR CUY CVF ECM EIF NPM 7QP 7T5 7XB 8FK H94 K9. MBDVC PJZUB PKEHL PPXIY PQEST PQUKI PUEGO Q9U 7X8 7S9 L.6 |
| ID | FETCH-LOGICAL-c545t-4dd00520d7bffa3e6dfc4112e954d801fb97540f02957015030b5de20be7f78d3 |
| IEDL.DBID | 7X7 |
| ISSN | 0007-1145 1475-2662 |
| IngestDate | Fri Jul 11 11:25:15 EDT 2025 Tue Aug 05 10:18:00 EDT 2025 Sat Aug 23 14:16:15 EDT 2025 Thu Apr 03 06:53:53 EDT 2025 Wed Apr 02 07:27:12 EDT 2025 Thu Apr 24 23:04:27 EDT 2025 Tue Jul 01 03:50:14 EDT 2025 Tue Jan 21 06:20:06 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | Metabolic profiling Flavonols Quercetin conjugates Dietary supplements Nutrition Metabolite Supplemented diet Antioxidant Metabolism Flavonoid Profile Feeding Micronutrient Polyphenol Quercetin Proanthocyanidin |
| Language | English |
| License | https://www.cambridge.org/core/terms CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c545t-4dd00520d7bffa3e6dfc4112e954d801fb97540f02957015030b5de20be7f78d3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://www.cambridge.org/core/services/aop-cambridge-core/content/view/CAFDA2F978EB611AA5C0307866452BA4/S0007114512003972a.pdf/div-class-title-dose-response-to-3-months-of-quercetin-containing-supplements-on-metabolite-and-quercetin-conjugate-profile-in-adults-div.pdf |
| PMID | 23151341 |
| PQID | 1400718691 |
| PQPubID | 5629 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_1825427427 proquest_miscellaneous_1353042522 proquest_journals_1400718691 pubmed_primary_23151341 pascalfrancis_primary_27382403 crossref_citationtrail_10_1017_S0007114512003972 crossref_primary_10_1017_S0007114512003972 cambridge_journals_10_1017_S0007114512003972 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2013-06-14 |
| PublicationDateYYYYMMDD | 2013-06-14 |
| PublicationDate_xml | – month: 06 year: 2013 text: 2013-06-14 day: 14 |
| PublicationDecade | 2010 |
| PublicationPlace | Cambridge, UK |
| PublicationPlace_xml | – name: Cambridge, UK – name: Cambridge – name: England |
| PublicationTitle | British journal of nutrition |
| PublicationTitleAlternate | Br J Nutr |
| PublicationYear | 2013 |
| Publisher | Cambridge University Press |
| Publisher_xml | – name: Cambridge University Press |
| References | Wishart, Knox, Guo (42) 2009; 37 Chen, Li, Luo (9) 2006; 14 Davis, Murphy, McClellan (11) 2008; 295 Vrijsen, Everaert, Boeye (12) 1988; 69 Shanely, Knab, Nieman (26) 2010; 44 Quash, Fournet (46) 2009; 16 Mullen, Edwards, Crozier (35) 2006; 96 Dias, Porawski, Alonso (4) 2005; 135 Neuhouser (18) 2004; 50 Comalada, Camuesco, Sierra (5) 2005; 35 Egert, Wolffram, Bosy-Westphal (25) 2008; 138 Egert, Bosy-Westphal, Seiberl (23) 2009; 102 Santos, Rodriguez-Gomez, Justino (34) 2008; 153 de Boer, Dihal, van der Woude (32) 2005; 135 Knab, Shanely, Henson (24) 2011; 111 Loke, Hodgson, Proudfoot (27) 2008; 88 Cushnie, Lamb (10) 2005; 26 Stipanuk, Ueki (45) 2011; 34 Bieger, Cermak, Blank (48) 2008; 138 Qiu, Cai, Su (40) 2009; 8 Lin, Yang, Lu (15) 2009; 33 Lodi, Jimenez, Moreno (47) 2009; 204 Loke, Proudfoot, McKinley (33) 2008; 56 Erdman, Balentine, Arab (19) 2007; 137 Zulyniak, Mutch (30) 2011; 12 Kanehisa, Goto, Furumichi (44) 2010; 38 Dimova, Mugabowindekwe, Willems (13) 2003; 263 Knekt, Kumpulainen, Jarvinen (17) 2002; 76 Qiu, Cai, Su (41) 2010; 9 Hodge, Patterson, Brown (37) 2000; 24 Ciz, Pavelkova, Gallova (2) 2008; 57 Root, McGinn, Nieman (39) 2012; 4 Edwards, Lyon, Litwin (22) 2007; 137 Najafzadeh, Reynolds, Baumgartner (3) 2009; 24 An, Zhang, Wu (14) 2010; 48 Heinz, Henson, Nieman (38) 2010; 104 Mimurai, Yazaki, Sawaki (43) 2005; 26 Nair, Mahajan, Reynolds (7) 2006; 13 Mink, Scrafford, Barraj (20) 2007; 85 Comalada, Ballester, Bailon (6) 2006; 72 Egert, Boesch-Saadatmandi, Wolffram (28) 2010; 140 Bakker, van Erk, Pellis (31) 2010; 91 Chiang, Chiang, Liu (8) 2003; 52 Boots, Drent, de Boer (29) 2011; 30 Nair, Kandaswami, Mahajan (16) 2002; 1593 Davis, Murphy, Carmichael (21) 2009; 296 Egert, Wolffram, Schulze (36) 2012; 107 S0007114512003972_ref30 S0007114512003972_ref31 S0007114512003972_ref18 S0007114512003972_ref19 S0007114512003972_ref34 S0007114512003972_ref12 S0007114512003972_ref13 S0007114512003972_ref35 S0007114512003972_ref32 S0007114512003972_ref10 S0007114512003972_ref11 S0007114512003972_ref33 S0007114512003972_ref38 S0007114512003972_ref16 S0007114512003972_ref39 S0007114512003972_ref17 S0007114512003972_ref36 S0007114512003972_ref14 S0007114512003972_ref37 S0007114512003972_ref15 S0007114512003972_ref3 S0007114512003972_ref4 S0007114512003972_ref1 S0007114512003972_ref7 S0007114512003972_ref41 S0007114512003972_ref42 S0007114512003972_ref8 S0007114512003972_ref20 S0007114512003972_ref5 S0007114512003972_ref40 S0007114512003972_ref6 S0007114512003972_ref9 Ciz (S0007114512003972_ref2) 2008; 57 S0007114512003972_ref29 S0007114512003972_ref45 S0007114512003972_ref23 S0007114512003972_ref24 S0007114512003972_ref46 S0007114512003972_ref21 S0007114512003972_ref43 S0007114512003972_ref44 S0007114512003972_ref22 S0007114512003972_ref27 S0007114512003972_ref28 S0007114512003972_ref47 S0007114512003972_ref25 S0007114512003972_ref48 S0007114512003972_ref26 |
| References_xml | – volume: 69 start-page: 1749 year: 1988 end-page: 1751 ident: 12 article-title: Antiviral activity of flavones and potentiation by ascorbate publication-title: J Gen Virol – volume: 37 start-page: D603 year: 2009 end-page: D610 ident: 42 article-title: HMDB: a knowledgebase for the human metabolome publication-title: Nucleic Acids Res – volume: 4 start-page: 29 year: 2012 end-page: 41 ident: 39 article-title: Combined fruit and vegetable intake is correlated with improved inflammatory and oxidant status from a cross-sectional study in a community setting publication-title: Nutrients – volume: 26 start-page: 343 year: 2005 end-page: 356 ident: 10 article-title: Antimicrobial activity of flavonoids publication-title: Int J Antimicrob Agents – volume: 56 start-page: 3609 year: 2008 end-page: 3615 ident: 33 article-title: Quercetin and its in vivo metabolites inhibit neutrophil-mediated low-density lipoprotein oxidation publication-title: J Agric Food Chem – volume: 16 start-page: 3686 year: 2009 end-page: 3700 ident: 46 article-title: Methionine-derived metabolites in apoptosis: therapeutic opportunities for inhibitors of their metabolism in chemoresistant cancer cells publication-title: Curr Med Chem – volume: 138 start-page: 1417 year: 2008 end-page: 1420 ident: 48 article-title: Tissue distribution of quercetin in pigs after long-term dietary supplementation publication-title: J Nutr – volume: 107 start-page: 539 year: 2012 end-page: 546 ident: 36 article-title: Enriched cereal bars are more effective in increasing plasma quercetin compared with quercetin from powder-filled hard capsules publication-title: Br J Nutr – volume: 137 start-page: 2405 year: 2007 end-page: 2411 ident: 22 article-title: Quercetin reduces blood pressure in hypertensive subjects publication-title: J Nutr – volume: 1593 start-page: 29 year: 2002 end-page: 36 ident: 16 article-title: The flavonoid, quercetin, differentially regulates Th-1 (IFNgamma) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells publication-title: Biochim Biophys Acta – volume: 50 start-page: 1 year: 2004 end-page: 7 ident: 18 article-title: Dietary flavonoids and cancer risk: evidence from human population studies publication-title: Nutr Cancer – volume: 96 start-page: 107 year: 2006 end-page: 116 ident: 35 article-title: Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions publication-title: Br J Nutr – volume: 135 start-page: 1718 year: 2005 end-page: 1725 ident: 32 article-title: Tissue distribution of quercetin in rats and pigs publication-title: J Nutr – volume: 24 start-page: 576 year: 2000 end-page: 583 ident: 37 article-title: The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation publication-title: Aust N Z J Public Health – volume: 13 start-page: 319 year: 2006 end-page: 328 ident: 7 article-title: The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system publication-title: Clin Vaccine Immunol – volume: 34 start-page: 17 year: 2011 end-page: 32 ident: 45 article-title: Dealing with methionine/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfur publication-title: J Inherit Metab Dis – volume: 137 start-page: 718S year: 2007 end-page: 737S ident: 19 article-title: Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31–June 1, 2005, Washington, DC publication-title: J Nutr – volume: 85 start-page: 895 year: 2007 end-page: 909 ident: 20 article-title: Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women publication-title: Am J Clin Nutr – volume: 88 start-page: 1018 year: 2008 end-page: 1025 ident: 27 article-title: Pure dietary flavonoids quercetin and ( − )-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men publication-title: Am J Clin Nutr – volume: 72 start-page: 1010 year: 2006 end-page: 1021 ident: 6 article-title: Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure–activity relationship publication-title: Biochem Pharmacol – volume: 102 start-page: 1065 year: 2009 end-page: 1074 ident: 23 article-title: Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study publication-title: Br J Nutr – volume: 38 start-page: D355 year: 2010 end-page: D360 ident: 44 article-title: KEGG for representation and analysis of molecular networks involving diseases and drugs publication-title: Nucleic Acids Res – volume: 111 start-page: 542 year: 2011 end-page: 549 ident: 24 article-title: Influence of quercetin supplementation on disease risk factors in community-dwelling adults publication-title: J Am Diet Assoc – volume: 8 start-page: 4844 year: 2009 end-page: 4850 ident: 40 article-title: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS publication-title: J Proteome Res – volume: 140 start-page: 278 year: 2010 end-page: 284 ident: 28 article-title: Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype publication-title: J Nutr – volume: 24 start-page: 405 year: 2009 end-page: 411 ident: 3 article-title: Flavonoids inhibit the genotoxicity of hydrogen peroxide (H(2)O(2)) and of the food mutagen 2-amino-3-methylimadazo[4,5-f]-quinoline (IQ) in lymphocytes from patients with inflammatory bowel disease (IBD) publication-title: Mutagenesis – volume: 57 start-page: 393 year: 2008 end-page: 402 ident: 2 article-title: The influence of wine polyphenols on reactive oxygen and nitrogen species production by murine macrophages RAW 264.7 publication-title: Physiol Res – volume: 295 start-page: R505 year: 2008 end-page: R509 ident: 11 article-title: Quercetin reduces susceptibility to influenza infection following stressful exercise publication-title: Am J Physiol Regul Integr Comp Physiol – volume: 138 start-page: 1615 year: 2008 end-page: 1621 ident: 25 article-title: Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans publication-title: J Nutr – volume: 104 start-page: 849 year: 2010 end-page: 857 ident: 38 article-title: A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects publication-title: Br J Nutr – volume: 135 start-page: 2299 year: 2005 end-page: 2304 ident: 4 article-title: Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats publication-title: J Nutr – volume: 153 start-page: 1750 year: 2008 end-page: 1761 ident: 34 article-title: Influence of the metabolic profile on the in vivo antioxidant activity of quercetin under a low dosage oral regimen in rats publication-title: Br J Pharmacol – volume: 14 start-page: 8295 year: 2006 end-page: 8306 ident: 9 article-title: Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure–activity relationship studies reveal salient pharmacophore features publication-title: Bioorg Med Chem – volume: 91 start-page: 1044 year: 2010 end-page: 1059 ident: 31 article-title: An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach publication-title: Am J Clin Nutr – volume: 204 start-page: 34 year: 2009 end-page: 39 ident: 47 article-title: Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta publication-title: Atherosclerosis – volume: 76 start-page: 560 year: 2002 end-page: 568 ident: 17 article-title: Flavonoid intake and risk of chronic diseases publication-title: Am J Clin Nutr – volume: 263 start-page: 95 year: 2003 end-page: 103 ident: 13 article-title: Safety-assessment of 3-methoxyquercetin as an antirhinoviral compound for nasal application: effect on ciliary beat frequency publication-title: Int J Pharm – volume: 12 start-page: 1005 year: 2011 end-page: 1015 ident: 30 article-title: Harnessing metabolomics for nutrition research publication-title: Curr Pharm Biotechnol – volume: 48 start-page: 1521 year: 2010 end-page: 1527 ident: 14 article-title: Changes of metabolic profiles in urine after oral administration of quercetin in rats publication-title: Food Chem Toxicol – volume: 44 start-page: 224 year: 2010 end-page: 231 ident: 26 article-title: Quercetin supplementation does not alter antioxidant status in humans publication-title: Free Radic Res – volume: 26 start-page: 139 year: 2005 end-page: 145 ident: 43 article-title: Hydroxyl radical scavenging effects of guaiacol used in traditional dental pulp sedation: reaction kinetic study publication-title: Biomed Res – volume: 52 start-page: 194 year: 2003 end-page: 198 ident: 8 article-title: In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids publication-title: J Antimicrob Chemother – volume: 296 start-page: R1071 year: 2009 end-page: R1077 ident: 21 article-title: Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance publication-title: Am J Physiol Regul Integr Comp Physiol – volume: 30 start-page: 506 year: 2011 end-page: 512 ident: 29 article-title: Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis publication-title: Clin Nutr – volume: 35 start-page: 584 year: 2005 end-page: 592 ident: 5 article-title: In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway publication-title: Eur J Immunol – volume: 9 start-page: 1627 year: 2010 end-page: 1634 ident: 41 article-title: Urinary metabonomic study on colorectal cancer publication-title: J Proteome Res – volume: 33 start-page: 823 year: 2009 end-page: 828 ident: 15 article-title: Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo publication-title: Leuk Res – ident: S0007114512003972_ref30 doi: 10.2174/138920111795909113 – ident: S0007114512003972_ref29 doi: 10.1016/j.clnu.2011.01.010 – ident: S0007114512003972_ref1 – ident: S0007114512003972_ref24 doi: 10.1016/j.jada.2011.01.013 – ident: S0007114512003972_ref8 doi: 10.1093/jac/dkg291 – ident: S0007114512003972_ref20 doi: 10.1093/ajcn/85.3.895 – ident: S0007114512003972_ref15 doi: 10.1016/j.leukres.2008.09.032 – ident: S0007114512003972_ref7 doi: 10.1128/CVI.13.3.319-328.2006 – ident: S0007114512003972_ref33 doi: 10.1021/jf8003042 – ident: S0007114512003972_ref46 doi: 10.2174/092986709789104966 – ident: S0007114512003972_ref23 doi: 10.1017/S0007114509359127 – ident: S0007114512003972_ref34 doi: 10.1038/bjp.2008.46 – ident: S0007114512003972_ref26 doi: 10.3109/10715760903407293 – ident: S0007114512003972_ref13 doi: 10.1016/S0378-5173(03)00363-6 – ident: S0007114512003972_ref42 doi: 10.1093/nar/gkn810 – ident: S0007114512003972_ref43 doi: 10.2220/biomedres.26.139 – ident: S0007114512003972_ref48 doi: 10.1093/jn/138.8.1417 – ident: S0007114512003972_ref32 doi: 10.1093/jn/135.7.1718 – ident: S0007114512003972_ref17 doi: 10.1093/ajcn/76.3.560 – ident: S0007114512003972_ref12 doi: 10.1099/0022-1317-69-7-1749 – ident: S0007114512003972_ref9 doi: 10.1016/j.bmc.2006.09.014 – ident: S0007114512003972_ref39 doi: 10.3390/nu4010029 – ident: S0007114512003972_ref28 doi: 10.3945/jn.109.117655 – ident: S0007114512003972_ref18 doi: 10.1207/s15327914nc5001_1 – ident: S0007114512003972_ref40 doi: 10.1021/pr9004162 – ident: S0007114512003972_ref10 doi: 10.1016/j.ijantimicag.2005.09.002 – ident: S0007114512003972_ref21 doi: 10.1152/ajpregu.90925.2008 – ident: S0007114512003972_ref37 doi: 10.1111/j.1467-842X.2000.tb00520.x – ident: S0007114512003972_ref31 doi: 10.3945/ajcn.2009.28822 – ident: S0007114512003972_ref25 doi: 10.1093/jn/138.9.1615 – ident: S0007114512003972_ref41 doi: 10.1021/pr901081y – ident: S0007114512003972_ref6 doi: 10.1016/j.bcp.2006.07.016 – ident: S0007114512003972_ref5 doi: 10.1002/eji.200425778 – ident: S0007114512003972_ref47 doi: 10.1016/j.atherosclerosis.2008.08.007 – ident: S0007114512003972_ref38 doi: 10.1017/S000711451000156X – ident: S0007114512003972_ref45 doi: 10.1007/s10545-009-9006-9 – ident: S0007114512003972_ref3 doi: 10.1093/mutage/gep016 – ident: S0007114512003972_ref4 doi: 10.1093/jn/135.10.2299 – ident: S0007114512003972_ref14 doi: 10.1016/j.fct.2010.03.019 – ident: S0007114512003972_ref36 doi: 10.1017/S0007114511003242 – ident: S0007114512003972_ref19 doi: 10.1093/jn/137.3.718S – ident: S0007114512003972_ref44 doi: 10.1093/nar/gkp896 – ident: S0007114512003972_ref35 doi: 10.1079/BJN20061809 – ident: S0007114512003972_ref27 doi: 10.1093/ajcn/88.4.1018 – volume: 57 start-page: 393 year: 2008 ident: S0007114512003972_ref2 article-title: The influence of wine polyphenols on reactive oxygen and nitrogen species production by murine macrophages RAW 264.7 publication-title: Physiol Res doi: 10.33549/physiolres.931088 – ident: S0007114512003972_ref22 doi: 10.1093/jn/137.11.2405 – ident: S0007114512003972_ref16 doi: 10.1016/S0167-4889(02)00328-2 – ident: S0007114512003972_ref11 doi: 10.1152/ajpregu.90319.2008 |
| SSID | ssj0008109 |
| Score | 2.2889435 |
| Snippet | Quercetin, a flavonol in fruits and vegetables, has been demonstrated to have antioxidant, anti-inflammatory and immunomodulating influences. The purpose of... |
| SourceID | proquest pubmed pascalfrancis crossref cambridge |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1923 |
| SubjectTerms | Adult adults Aged Aged, 80 and over antioxidants Antioxidants - administration & dosage Antioxidants - pharmacokinetics Antioxidants - pharmacology ascorbic acid Ascorbic Acid - administration & dosage Ascorbic Acid - pharmacokinetics bile acids Biological and medical sciences blood sampling blood serum body mass index Dietary Supplements discriminant analysis dose response Dose-Response Relationship, Drug Drug Interactions Feeding. Feeding behavior Female fruits Fundamental and applied biological sciences. Psychology guaiacol Humans least squares Liquid chromatography Male men Metabolism Metabolism and Metabolic Studies Metabolites Middle Aged niacin Niacin - administration & dosage Niacin - pharmacokinetics Oxidative stress placebos Polyphenols quercetin Quercetin - administration & dosage Quercetin - pharmacology statistical models ultra-performance liquid chromatography vegetables Vertebrates: anatomy and physiology, studies on body, several organs or systems vitamin D women |
| Title | Dose–response to 3 months of quercetin-containing supplements on metabolite and quercetin conjugate profile in adults |
| URI | https://www.cambridge.org/core/product/identifier/S0007114512003972/type/journal_article https://www.ncbi.nlm.nih.gov/pubmed/23151341 https://www.proquest.com/docview/1400718691 https://www.proquest.com/docview/1353042522 https://www.proquest.com/docview/1825427427 |
| Volume | 109 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_8eBFE_LZ-jAjig1hsl3Rpn8RPRHCIKOxttE2CirZz7f5_79q0U8S9jLHl1ix3yV0ul98P4MhTMtQ6xp2qCFOiMEvdOAkNvkN7ihMR6IqL4KHfu3sR94NgYBNuhS2rbNbEaqFWeUo58jOfCLyJP8k_H325xBpFp6uWQmMeFgm6jKxaDtoNF3o7W-JBQIi-CJpTzQoymn6OaGqpOisigOAptsIvH7U8igscLlPzXPwfiFYO6XYVVmwkyS5q1a_BnM7Wwbl-0yU7Zhbu84P1G7T9DZhc54V2x3VRrGZlzjjDf1W-Fiw3DB82Tun-s0vV6zVvBCuI87NKIGKbjH3qEm2Gbi2zOFNTEYYi7xNKyDHLAc7wwwrao9iEl9ub56s717IuuClGU6UrlKqKY5RMjIm57imTCozKdBQIhf7MJJHEMM943SiQlC_hXhIoVGmipZGh4luwkOWZ3gHmSxxdgb4xVZFQXCS8h-tZyP3YeNJ4ngOn7ZgP7dwphnXdmRz-UZEDXqOWYWoRzIlI42OWyEkrMqrhO2Y17vzSdStB15cIt9CB_Ub5P7rbGqYDh-3XOEnp5CXOdD7BNjygtBHGujPa0F6dDs6lA9u1YU07wDEww3hjd3YH9mCpW7N1uL7Yh4VyPNEHGDOVSaeaGPgaXvkdWLy86T8-fQMj5xDk |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwED6N8QASQvwmMMYhAQ-IaEnt1MnDNKGVqWNbnzZpbyGJbQEaSWlSTfun-Bu5i5OUCdG3vVWprz35zvblfPd9AG8DrWJjMnpTlXHBFGaFn-WxpU_kT1kuI9NyEZzMxtMz-eU8Ot-A330vDJdV9ntiu1HrquAc-U7IBN7MnxTuzX_5zBrFt6s9hYZziyNzdUmvbPXu4YTs-240Ovh8uj_1O1YBv6BoofGl1m3xh1a5tZkwY20LSVGHSSKpab-2eaIojLHBKIkU5wNEkEeaVM6NsirWgn73FtyWgpYmd6bvr0pK4rArKWHgxVBG_S1qC1HN6jMtLleDJQxIvMJyuHYm3ptnNZnHOl6N_we-7QF48ADud5ErfnKu9hA2TPkIvMl30-B77OBFL3DWo_s_huWkqo2_cEW4BpsKBdIsNt9qrCzSny0K7rf2uVre8VRgzRyjbcKSxpT40zTko9wljVmpVyJIIj-WnADEjnMc6WELJVI_gbMbscdT2Cyr0jwHDBXNrqSzuNCJ1ELmYkxGikWY2UDZIPDg4zDnabdW69TVuan0HxN5EPRmSYsOMZ2JOy7WiXwYROYOLmTd4O1rth4kuF2KcRI92OqN_5e6w0Lw4M3wNW0KfNOTlaZa0hgRcZqKYus1Yzg3wBf1yoNnzrFWCggKBCm-ebFegddwZ3p6cpweH86OXsLdkWMK8UO5BZvNYmleUbzW5NvtIkH4etOr8g_k80py |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NISGkaeJ7GWMcEvCAiJbUTp08IIRWqo1BxQOT9haS2BabRlKaVIh_jb-OuzhJmRB921vV-lrX9-HL-fz7ATwPtIqNyehJVcYFU5gVfpbHll6RPWW5jEzLRfBpNj46lR_OorMN-N3fheG2yj4mtoFaVwXXyA9CJvBm_qTwwHZtEZ8n07fzHz4zSPFJa0-n4UzkxPz6SY9v9ZvjCen6xWg0ff_l8MjvGAb8gjKHxpdat40gWuXWZsKMtS0kZSAmiaSm2G3zRFFKY4NREimuDYggjzRNPzfKqlgL-t4bcFMJFbOPxYer9pI47NpLGIQxlFF_otrCVfNfYYpc7gxLGJx4hetwZX_cmmc1qco6jo3_J8HtZji9A9tdFovvnNndhQ1T3gNvcm4afIkd1Oglznqk__uwnFS18ReuIddgU6FAWsXmW42VRfqxRcF3r33unHecFVgz32hbvKQxJX43Ddkr35jGrNQrESSRiyUXA7HjH0d6s4UVqR_A6bXo4yFsllVpdgBDRasraV8udCK1kLkYUyyNRZjZQNkg8OD1sOZp57d16nreVPqPijwIerWkRYeeziQel-tEXg0icwcdsm7w_hVdDxJ8dYoxEz3Y65X_13QHp_Dg2fAxBQg-9clKUy1pjIi4ZEV59poxXCfgQ3vlwSNnWKsJCEoKKdfZXT-Bp3CL_DH9eDw7eQy3R440xA_lHmw2i6V5Qqlbk--3PoLw9bqd8g-tBk6o |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dose-response+to+3+months+of+quercetin-containing+supplements+on+metabolite+and+quercetin+conjugate+profile+in+adults&rft.jtitle=British+journal+of+nutrition&rft.au=CIALDELLA-KAM%2C+Lynn&rft.au=NIEMAN%2C+David+C&rft.au=WEI+SHA&rft.au=MEANEY%2C+Mary+Pat&rft.date=2013-06-14&rft.pub=Cambridge+University+Press&rft.issn=0007-1145&rft.volume=109&rft.issue=11&rft.spage=1923&rft.epage=1933&rft_id=info:doi/10.1017%2Fs0007114512003972&rft.externalDBID=n%2Fa&rft.externalDocID=27382403 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1145&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1145&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1145&client=summon |